These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17479917)

  • 21. Risk of Plasmodium falciparum infection during a malaria epidemic in highland Kenya, 1997.
    John CC; Koech DK; Sumba PO; Ouma JH
    Acta Trop; 2004 Sep; 92(1):55-61. PubMed ID: 15301975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artemether-Lumefantrin (Coartem) and artesunate with sulfadoxine-pyrimethamine therapeutic efficacy in the treatment of uncomplicated malaria at Gilgel Gibe II (GGII) South-Western Ethiopia.
    Seboxa T; Mao P; Pinchouk N; Anbessie J; Alemu H; Diro E
    Ethiop Med J; 2010 Oct; 48(4):285-91. PubMed ID: 21280430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
    Omar SA; Mens PF; Schoone GJ; Yusuf A; Mwangi J; Kaniaru S; Omer GA; Schallig HD
    Exp Parasitol; 2005 May; 110(1):73-9. PubMed ID: 15804381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sulfadoxin pyrimethamine for uncomplicated Plasmodium falciparum malaria in a small sample of Sudanese children.
    Adam I; Ibrahim MH; A/elbasit IA; Elbashir MI
    East Mediterr Health J; 2004 May; 10(3):309-14. PubMed ID: 16212206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
    Garg MR; Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
    Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacies of chloroquine, pyrimethamine/sulphadoxine and pyrimethamine/sulphalene against P. falciparum in northeastern Nigeria.
    Molta NB; Daniel HI; Watila IM; Oguche SO; Otu TI; Ameh JO; Gadzama NM
    J Trop Med Hyg; 1992 Aug; 95(4):253-9. PubMed ID: 1495121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: sulfadoxine-pyrimethamine is not working in Malawi.
    White N
    BMJ; 2004 May; 328(7450):1259; author reply 1260. PubMed ID: 15155511
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R; Basco LK
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma HIV viral load in relation to season and to Plasmodium falciparum parasitaemia.
    Ariyoshi K; Schim van der Loeff M; Berry N; Jaffar S; Whittle H
    AIDS; 1999 Jun; 13(9):1145-6. PubMed ID: 10397550
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV-1 viral load and scrub typhus.
    Ariyoshi K; Whittle H
    Lancet; 2000 Nov; 356(9243):1766; author reply 1766-7. PubMed ID: 11095279
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of malaria on HIV-1 progression and transmission.
    Whitworth JA; Hewitt KA
    Lancet; 2005 Jan 15-21; 365(9455):196-7. PubMed ID: 15652587
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytes.
    Ludlow LE; Zhou J; Tippett E; Cheng WJ; Hasang W; Rogerson SJ; Jaworowski A
    PLoS One; 2012; 7(2):e32102. PubMed ID: 22363802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of HIV-1 infection on the hematological recovery after clinical malaria.
    Van Geertruyden JP; Mulenga M; Chalwe V; Michael N; Moerman F; Mukwamataba D; Colebunders R; D'alessandro U
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):200-5. PubMed ID: 19131887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe malaria.
    Trop Med Int Health; 2014 Sep; 19 Suppl 1():7-131. PubMed ID: 25214480
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental systems for studying Plasmodium/HIV coinfection.
    Frischknecht F; Fackler OT
    FEBS Lett; 2016 Jul; 590(13):2000-13. PubMed ID: 27009943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Malaria: a medical emergency].
    Berens-Riha N; Nothdurft HD; Löscher T
    Dtsch Med Wochenschr; 2012 Nov; 137(47):2429-46. PubMed ID: 23152071
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppressed circulating bicyclo-PGE2 levels and leukocyte COX-2 transcripts in children co-infected with P. falciparum malaria and HIV-1 or bacteremia.
    Anyona SB; Kempaiah P; Davenport GC; Vulule JM; Hittner JB; Ong'echa JM; Perkins DJ
    Biochem Biophys Res Commun; 2013 Jul; 436(4):585-90. PubMed ID: 23743193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1-infected individuals traveling to malaria endemic areas.
    Van Geertruyden JP; Colebunders R; D'alessandro U
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):234-5. PubMed ID: 19465828
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV-1 viral load and scrub typhus.
    Colebunders R; Fransen K; Florence E; Vanham G
    Lancet; 2000 Nov; 356(9243):1765-6; author reply 1766-7. PubMed ID: 11095278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.